SpaceX's Falcon 9 rocket and Crew Dragon capsule will take four astronauts to the International Space Station for six months before returning them to Earth.
"It's historic because even things like the certification of the space flight had to be done by the FAA this time instead of NASA because it's commercial," NASA Astronaut Dr. Peggy Whitson told Cheddar on Thursday.
The launch, made possible through a private-public partnership, is scheduled for 7:49 p.m. ET on Saturday from Kennedy Space Center in Florida.
The launch will be simulcast on Discovery and the Science Channel where Whitson and other astronauts will help viewers understand the space flight experience better as they watch the Falcon 9 rocket pierce through the atmosphere.
"I think the folks will find it interesting," Whitson said. "When you go from zero to 17,500 miles-an-hour in nine minutes, it's a pretty good ride."
Whitson says getting the private sector involved in space travel and advancement could help with the development of new technologies and medicines. She even thinks a lunar space station could be in the cards in the future.
"It has the potential to open up commercial markets in space," Whitson said. "I've done enough research onboard the space station that I really feel it's going to be an important tool for us to advance technologies here on the ground as well."
The retired astronaut holds the records for most time spent in space by any American (665 days), as well as being the first woman to command the International Space Station twice (2008 and 2013).
"You've got to challenge yourself to live outside your comfort zone. Challenge yourself to do things that are not easy," Whitson said. "You will find that you can achieve so much more than you even dreamed about."
On Monday, football fans were stunned when Buffalo Bills safety Damar Hamlin collapsed and suffered cardiac arrest. Cheddar News explains the condition and the steps to take if you witness an incident.
What's being called an unprecedented breakthrough in cancer treatment recently completed a small trial at New York City's Memorial Sloan Kettering in 14 rectal cancer patients. The experimental trial with the drug dostarlimab resulted in 100 percent remission in all candidates, precluding the need for chemotherapy or surgery. Cheddar News anchor Hena Doba dives into this hopeful story.
Join Cheddar News as we break down the top headlines this morning including updates on the Jan. 6 hears, the PGA suspension of 17 of the world's best golfers, and NASA's plans to study UFOs.
Rick Pauls, President & CEO OF DiaMedica Therapeutics, joins Cheddar Innovates to discuss a new ischemic stroke treatment option that expands the window for effective therapy for stroke patients.
John Bencich, CEO of Achieve Life Sciences, joins Cheddar Innovates to discuss a new plant-based compound that's being used to fight nicotine addiction.
On this episode of Cheddar Innovates: CEO of Achieve Life Sciences discusses a new plant-based compound that's being used to fight nicotine addiction; President & CEO OF DiaMedica Therapeutics explains a new ischemic stroke treatment option that expands the window for effective therapy for stroke patients; Cheddar gets a look at Curiosity Stream's 'Asteroid Rush.'
